Cargando…
Induction of Drug Transporters Alters Disposition of Risperidone - A Study in Mice
Pharmacokinetic interactions, e.g. modulation of drug transporters like P-glycoprotein at the blood-brain barrier, can be a reason for treatment non-response. This study focuses on the influence of induction of drug transporters on the disposition of the antipsychotic drugs risperidone and 9-hydroxy...
Autores principales: | Holthoewer, David, Hiemke, Christoph, Schmitt, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986720/ https://www.ncbi.nlm.nih.gov/pubmed/27721355 http://dx.doi.org/10.3390/pharmaceutics2020258 |
Ejemplares similares
-
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
por: Mooij, Miriam G., et al.
Publicado: (2015) -
Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
por: Lozano, Elisa, et al.
Publicado: (2018) -
Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity
por: Chiang, Po-Chang, et al.
Publicado: (2014) -
The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition
por: Zazuli, Zulfan, et al.
Publicado: (2020) -
Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition
por: Parvez, Md Masud, et al.
Publicado: (2023)